☆ 4.4 Letter

Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement

HAEMATOLOGICA (2015)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 100, Issue 3, Pages E99-E101

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2014.114579

Keywords

AML; molecular MRD; AML1-ETO; RUNX1-RUNX1T1; CBFB-MYH11; pediatric; RQ-PCR; AIEOP; t(8;21); inv(16)

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.